FCER2 and neoplasm: We next evaluated tissue from tumor bearing mice (tumor mass, spleen, intestine and kidney) by immunohistochemical analysis for the expression of CD3, CD5, CD19, CD20, CD23, CD45, CD79a, Ki-67, cyclin D1, and Pax5.